Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Karri A Bauer, PharmD

Merck Research Laboratories

Disclosure(s): Merck & Co., Inc. Merck Research Laboratories: Stocks/Bonds

Poster(s):

1670 - Activity of Ceftolozane/Tazobactam and Comparators Against Clinical MDR and DTR Pseudomonas aeruginosa isolates – SMART United States 2018-2020
Saturday, October 22, 2022
12:15 PM – 1:30 PM US ET
1671 - Activity of Imipenem/Relebactam and Comparators Against Gram-Negative MDR and DTR Pathogens from Patients with Respiratory and Bloodstream Infections – SMART United States 2018-2020
Saturday, October 22, 2022
12:15 PM – 1:30 PM US ET